GM Biotech's strong product range and dynamic management team have lead to increasing sales year on year.

A highly focused PR department has kept our organisation in a favourable light, reducing the marketing spend considerably.

Aggressive selling in the field has produced heavy take up of our product range.

Cash reserves stand at $200 million.
Assets value at $2 billion.
Total outstanding debt $700 million.
Turn-over $500 million.
Profit before tax $150 million.